Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kövesi, T.
Right arrow Articles by Royston, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kövesi, T.
Right arrow Articles by Royston, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2002, Vol. 88, No. 2 159-163
© 2002 The Board of Management and Trustees of the British Journal of Anaesthesia


Editorial

Editorial I

Is there a bleeding problem with platelet-active drugs?

T. Kövesi and D. Royston

Platelets provide for primary haemostasis by forming a plug at sites of vascular damage. After initial adhesion, platelets aggregate to effect haemostatic plug formation. Platelet aggregation requires active platelet metabolism; stimulation by agonists such as adenosine diphosphate (ADP) or thrombin; divalent cations; specific plasma proteins such as fibrinogen; and a platelet receptor, the glycoprotein IIb/IIIa (GP IIb/IIIa) complex. Activation of the GP IIb/IIIa receptor on the platelet surface is the final pathway of platelet aggregation, regardless of the initiating stimulus. During aggregation, ADP is released from the platelet to autoactivate its own receptor, thromboxane A2 (TxA2) is synthesized, and preformed serotonin is released to promote microvascular constriction, helping the plug to form a more solid hold on wound edges.

Platelet-active medications have diverse mechanisms of action, pharmacodynamic and adverse effect profiles. All the current drugs can prolong the skin bleeding time. One of the perceived risks of platelet active . . . [Full Text of this Article]

Non-steroidal anti-inflammatory drugs (NSAIDs)

Spontaneous bleeding
Surgical bleeding
Specific therapy to reduce bleeding
Purinergic or adenosine diphosphate receptor blockers

Spontaneous bleeding
Surgical bleeding
Specific therapy to reduce bleeding
Platelet glycoprotein receptor (GPIIb/IIIa) antagonists

Spontaneous bleeding
Surgical bleeding
Specific therapy to reduce bleeding
References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
S. Bengeri, S. Bolsin, L. Broad, M. Conroy, S. Black, N. Orford, and G. Birdsey
Successful management of patients with a drug-eluting coronary stent presenting for elective surgery
Br. J. Anaesth., June 1, 2007; 98(6): 841 - 842.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
G. M. Howard-Alpe, J. de Bono, L. Hudsmith, W. P. Orr, P. Foex, and J. W. Sear
Coronary artery stents and non-cardiac surgery
Br. J. Anaesth., May 1, 2007; 98(5): 560 - 574.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
G. Scharbert, E. Deusch, H. G. Kress, M. Greher, B. Gustorff, and S. A. Kozek-Langenecker
Inhibition of Platelet Function by Hydroxyethyl Starch Solutions in Chronic Pain Patients Undergoing Peridural Anesthesia
Anesth. Analg., September 1, 2004; 99(3): 823 - 827.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. T. Horlocker, Z. H. Bajwa, Z. Ashraf, S. Khan, J. L. Wilson, N. Sami, C. Peeters-Asdourian, C. A. Powers, D. R. Schroeder, P. A. Decker, et al.
Risk Assessment of Hemorrhagic Complications Associated with Nonsteroidal Antiinflammatory Medications in Ambulatory Pain Clinic Patients Undergoing Epidural Steroid Injection
Anesth. Analg., December 1, 2002; 95(6): 1691 - 1697.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. Innerhofer, D. Fries, J. Margreiter, A. Klingler, G. Kuhbacher, B. Wachter, E. Oswald, E. Salner, B. Frischhut, and W. Schobersberger
The Effects of Perioperatively Administered Colloids and Crystalloids on Primary Platelet-Mediated Hemostasis and Clot Formation
Anesth. Analg., October 1, 2002; 95(4): 858 - 865.
[Abstract] [Full Text] [PDF]